AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
Authors
Keywords
-
Journal
Biomarker Research
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-12
DOI
10.1186/s40364-020-00208-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
- (2020) Courtney D. DiNardo et al. BLOOD
- Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
- (2019) Cheng-Hong Tsai et al. EBioMedicine
- Prognostic Value of Genetic Alterations in Elderly Patients with Acute Myeloid Leukemia: A Single Institution Experience
- (2019) Maël Heiblig et al. Cancers
- Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia
- (2019) Konstanze Döhner et al. BLOOD
- Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report
- (2018) Era L. Pogosova-Agadjanyan et al. BIOPRESERVATION AND BIOBANKING
- Acute myeloid leukemia in very old patients
- (2018) Vladimir Lj Lazarevic et al. HAEMATOLOGICA
- Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies
- (2018) Ann-Kathrin Eisfeld et al. LEUKEMIA
- Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study
- (2018) Yasuhiko Harada et al. LEUKEMIA RESEARCH
- Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report
- (2018) Era L. Pogosova-Agadjanyan et al. Biopreservation and Biobanking
- Acute myeloid leukemia in very old patients
- (2018) Vladimir Lj Lazarevic et al. HAEMATOLOGICA
- The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia
- (2018) Nicolas Duployez et al. LEUKEMIA
- Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3 -internal tandem duplication genotypes
- (2018) Prajwal C. Boddu et al. CANCER
- Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients
- (2018) Xin-xin Cao et al. Cancer Cell International
- The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia
- (2017) A-K Eisfeld et al. LEUKEMIA
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
- (2016) K. H. Metzeler et al. BLOOD
- Cell cycle status in AML blast cells from peripheral blood, bone marrow aspirates and trephines and implications for biological studies and treatment
- (2016) Rob S. Sellar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms
- (2016) Chun Hang Au et al. Diagnostic Pathology
- Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
- (2016) C-H Tsai et al. LEUKEMIA
- A 17-gene stemness score for rapid determination of risk in acute leukaemia
- (2016) Stanley W. K. Ng et al. NATURE
- COSMIC: somatic cancer genetics at high-resolution
- (2016) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
- (2016) Hsin-An Hou et al. Oncotarget
- High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia
- (2016) Lin Fu et al. Oncotarget
- An integrative approach to predicting the functional effects of non-coding and coding sequence variation
- (2015) Hashem A. Shihab et al. BIOINFORMATICS
- A 4-gene expression score associated with high levels ofWilms Tumor-1 (WT1)expression is an adverse prognostic factor in acute myeloid leukaemia
- (2015) Ahmadreza Niavarani et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prognostic Significance ofNPM1Mutations in the Absence ofFLT3–Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report
- (2015) Fabiana Ostronoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with acute myeloid leukemia
- (2014) W.-G. Tong et al. HAEMATOLOGICA
- A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
- (2013) S. H. Petersdorf et al. BLOOD
- A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia
- (2013) K H Metzeler et al. LEUKEMIA
- A simple consensus approach improves somatic mutation prediction accuracy
- (2013) David L Goode et al. Genome Medicine
- Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen
- (2012) S. Ochsenreither et al. BLOOD
- Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias: A Study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group
- (2012) Stefan Gröschel et al. JOURNAL OF CLINICAL ONCOLOGY
- Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia
- (2011) S. Schwind et al. BLOOD
- Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers
- (2011) V. Rockova et al. BLOOD
- WT1 overexpression at diagnosis may predict favorable outcome in patients withde novonon-M3 acute myeloid leukemia
- (2011) Maurizio Miglino et al. LEUKEMIA & LYMPHOMA
- Stem cell gene expression programs influence clinical outcome in human leukemia
- (2011) Kolja Eppert et al. NATURE MEDICINE
- BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
- (2010) S. Schwind et al. BLOOD
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- (2010) K. Wang et al. NUCLEIC ACIDS RESEARCH
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia
- (2009) Thomas R. Chauncey et al. BRITISH JOURNAL OF HAEMATOLOGY
- Favorable Prognostic Impact ofNPM1Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study
- (2009) Heiko Becker et al. JOURNAL OF CLINICAL ONCOLOGY
- High correlation of the proteome patterns in bone marrow and peripheral blood blast cells in patients with acute myeloid leukemia
- (2009) Gero Hütter et al. Journal of Translational Medicine
- What is the impact of hematopoietic cell transplantation (HCT) for older adults with acute myeloid leukemia (AML)?
- (2008) Frederick R. Appelbaum BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study
- (2008) C. Langer et al. BLOOD
- Identification of genes with abnormal expression changes in acute myeloid leukemia
- (2007) Derek L. Stirewalt et al. GENES CHROMOSOMES & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started